Filed: 11/14/2023ACC: 0001420506-23-002134
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $191.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$191.74M
Total AUM (reported)
38.44M
Total Shares
Allocation by class
COM$127.81M66.7%
COM NEW$21.21M11.1%
PUT$17.91M9.3%
SPONSORED ADS$7.82M4.1%
CLASS A ORD$5.02M2.6%
CL A$4.57M2.4%
COM SER A$4.25M2.2%
Portfolio Concentration
Top 3$34.95M18.2%
4–10$64.12M33.4%
11–25$67.53M35.2%
Rest$25.14M13.1%
Top 3 weight
18.2%
Top 10 weight
51.7%
Voting Authority Distribution
Total shares with voting rights: 38.44M
Sole
Full voting authority
38.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
CYMABAY THERAPEUTICS INC
SOLEShares800K
TypeSH
Market value$11.93M
6.22%
Sole
800K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares300K
TypeSH
Market value$11.52M
6.01%
Sole
300K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares725K
TypeSH
Market value$11.51M
6.00%
Sole
725K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1.35M
TypeSH
Market value$10.05M
5.24%
Sole
1.35M
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares8.93M
TypeSH
Market value$9.83M
5.13%
Sole
8.93M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares534.70K
TypeSH
Market value$9.79M
5.11%
Sole
534.70K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares2.72M
TypeSH
Market value$9.75M
5.08%
Sole
2.72M
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares2.93M
TypeSH
Market value$9.10M
4.74%
Sole
2.93M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares155K
TypeSH
Market value$7.82M
4.08%
Sole
155K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares262K
TypeSH
Market value$7.79M
4.06%
Sole
262K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares228K
TypeSH
Market value$7.79M
4.06%
Sole
228K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares287K
TypeSH
Market value$7.46M
3.89%
Sole
287K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares92K
TypeSH
Market value$6.43M
3.35%
Sole
92K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares34K
TypeSH
Market value$5.75M
3.00%
Sole
34K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares88K
TypeSH
Market value$5.02M
2.62%
Sole
88K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares333.68K
TypeSH
Market value$4.57M
2.39%
Sole
333.68K
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
SOLEShares483.18K
TypeSH
Market value$4.25M
2.22%
Sole
483.18K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares335K
TypeSH
Market value$4.14M
2.16%
Sole
335K
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares117K
TypeSH
Market value$3.83M
2.00%
Sole
117K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$3.80M
1.98%
Sole
100K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares29.30K
TypeSH
Market value$3.55M
1.85%
Sole
29.30K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares315K
TypeSH
Market value$2.82M
1.47%
Sole
315K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares403K
TypeSH
Market value$2.76M
1.44%
Sole
403K
Shared
0.00
None
0.00
ACUMEN PHARMACEUTICALS INC
SOLEShares650K
TypeSH
Market value$2.70M
1.41%
Sole
650K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares155K
TypeSH
Market value$2.65M
1.38%
Sole
155K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYMABAY THERAPEUTICS INCSOLE | COM | 800K | SH | $11.93M 6.22% | 800K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | PUT | 300K | SH | $11.52M 6.01% | 300K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 725K | SH | $11.51M 6.00% | 725K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1.35M | SH | $10.05M 5.24% | 1.35M | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 8.93M | SH | $9.83M 5.13% | 8.93M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 534.70K | SH | $9.79M 5.11% | 534.70K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 2.72M | SH | $9.75M 5.08% | 2.72M | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 2.93M | SH | $9.10M 4.74% | 2.93M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 155K | SH | $7.82M 4.08% | 155K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 262K | SH | $7.79M 4.06% | 262K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 228K | SH | $7.79M 4.06% | 228K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 287K | SH | $7.46M 3.89% | 287K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 92K | SH | $6.43M 3.35% | 92K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 34K | SH | $5.75M 3.00% | 34K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 88K | SH | $5.02M 2.62% | 88K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 333.68K | SH | $4.57M 2.39% | 333.68K | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 483.18K | SH | $4.25M 2.22% | 483.18K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 335K | SH | $4.14M 2.16% | 335K | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 117K | SH | $3.83M 2.00% | 117K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | PUT | 100K | SH | $3.80M 1.98% | 100K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 29.30K | SH | $3.55M 1.85% | 29.30K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 315K | SH | $2.82M 1.47% | 315K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 403K | SH | $2.76M 1.44% | 403K | 0.00 | 0.00 |
ACUMEN PHARMACEUTICALS INCSOLE | COM | 650K | SH | $2.70M 1.41% | 650K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 155K | SH | $2.65M 1.38% | 155K | 0.00 | 0.00 |
Page 1 of 3